Press Release | July 26, 2023

Kincell Bio Launches

Kincell Bio, a technology-forward contract development and manufacturing organization (CDMO) focused on cell therapies, today emerged from stealth with $36 million in new funding. Kineticos Ventures led Kincell’s launch funding. Kincell is a spinout of Inceptor Bio’s CMC, manufacturing and quality organizations formed to accelerate innovator research and clinical trials. Kincell acquires a facility and a fully staffed team based at its Gainesville site, with plans to grow in Gainesville, as well as in additional key markets, such as Research Triangle Park (RTP), Boston and other customer locations. Kincell offers analytical development, process development, CMC consulting and early-stage GMP manufacturing […]

Read More